Clinical trial
Glucose Tolerance and Its Clinical Impact in Children and Adolescents With Cystic Fibrosis
NCT02569229 is registered in ClinicalTrials.gov with Christoph Saner as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucose Tolerance and Its Clinical Impact in Children and Adolescents With Cystic Fibrosis
- Lead sponsor
- Christoph Saner
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- November 18, 2016
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.